Donor

Carolina’s Collaborative Culture

“Embracing a collaborative culture is critical...”

“Embracing a collaborative culture is critical...”

Lindsey Ingerman James ’10 (Ph.D.) was on the front lawn of Beard Hall with other Carolina professors when the largest gift from an individual in University history, and the largest ever made to a U.S. pharmacy school, was announced.

“It was clear that this gift was unprecedented, that we as a school of pharmacy were extremely fortunate and that the Eshelman Institute for Innovation would be quite impactful,” James says. “But what I didn’t grasp at the time was how this gift was going to directly impact my research program and career.”

It wasn’t until 2018, when James received her first EII grant, that she understood.

“The EII grants can be really critical in kick-starting the careers of young faculty like myself,” she says. “The outreach efforts at EII are quite extensive, and these opportunities presented by EII help to progress our science in ways that wouldn’t otherwise be possible.”

James is part of a team that studies a group of proteins that help to regulate genes without changing DNA sequences. Such phenomena, known as epigenetics, can help to explain certain differences between identical twins who have the same DNA.

“It’s becoming increasingly clear that epigenetic changes can be responsible for various disease states,” she says. “One of our primary goals is to validate new epigenetic targets for drug discovery. … if we can demonstrate that blocking a specific protein function has a potential therapeutic benefit, I’d consider that a huge success.”

James feels the collaborative culture at Carolina and the UNC Eshelman School of Pharmacy distinguishes the university while making research programs more productive.

“Most of the research projects I work on are a collaboration with at least one other faculty member. It’s what makes them so successful,” she says. “Most of today’s research is multidisciplinary and one lab cannot do it all, so embracing a collaborative culture is critical.”

The Eshelman Institute for Innovation is made possible by a $100 million gift from Fred Eshelman to accelerate the creation and development of ideas leading to discoveries and transformative changes in education, research and health care. To learn more about the EII’s impact, visit unceii.org/impactOpens in new window.

UNC Eshelman School of Pharmacy Funding Priorities

    Readers Also Viewed...

    A group shot of Owen Fenton and his team in the Fenton Lab
    Faculty Support

    Attracting Expertise

    Owen Fenton sees coming to Carolina as a win for his research interests.

    Tim Willson stands with arms crossed with lab equipment in the background.
    Faculty Support

    Bringing the dark proteome into the light

    A Q&A with Tim Willson, the inaugural Harold Kohn Distinguished Professor in Open Science Drug Discovery

    A UNC Eshelman School of Pharmacy student takes notes during class.
    Health

    Strengthening Diversity, Improving Care

    Grants to the UNC Eshelman School of Pharmacy will support diversity and rural care programs.

    Nate Hathaway in the CRISPR Screening Facility
    Research

    UNC-Chapel Hill Awarded Funding for Study of Malan Syndrome

    UNC Eshelman School of Pharmacy and CRISPR Screening Facility collaborate on Malan Syndrome study.

    Health

    Smarter Organ Transplants

    The UNC Eshelman Institute for Innovation's Venture Studio invested in technology for smarter organ transplants.

    Shawn Hingtgen and Jillian Perry
    Research

    Treating the Untreatable

    New research funded by a NIH grant seeks to combat one of the most treatment-resistant cancers